EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Outer Membrane Vesicles Derived From Klebsiella pneumoniae Aggravate Primary Sclerosing Cholangitis in Mdr2 −/− Mice and IL‐17A‐Stimulated Cholangiocyte Organoids

Pengyu Yin, Kaicen Wang, Yechen Wu, Fengjiao Wang, Yuxi Zhao, Jiali Ni, Tinglei Song, Yanfei Chen, Lanjuan Li iD

Journal of Extracellular Vesicles · 2026-11 · 15 (11)

DOI: 10.1002/jev2.70402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 15.11.2026. Verfasst von Pengyu Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore B…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Klebsiella pneumoniae, Interleukin-17, Organoids. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key R&D Program of Shandong Province, National Key R&D Program of China, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by chronic inflammation and biliary stricture; however, its pathogenesis remains poorly understood. PSC patients frequently have coexisting inflammatory bowel disease (IBD), accompanied by a pronounced enrichment of Klebsiella pneumoniae in the gut. Given the crucial role of bacterial outer membrane vesicles (OMVs) in disease pathogenesis, we hypothesize that K. pneumoniae ‐derived OMVs (Kp‐OMVs) serve as key mediators between the gut and liver in PSC. In Mdr2 −/− mice, Kp‐OMVs exacerbated PSC, with increased cholestatic liver injury, fibrosis, and bile duct hyperplasia. Hepatic transcriptomics revealed significant activation of multiple pro‐inflammatory pathways, along with marked suppression of glutathione metabolism, detoxification, and bile secretion. Moreover, Kp‐OMVs disrupted the intestinal barrier, promoted endotoxin translocation, and disturbed the gut‐liver microecology in Mdr2 −/− mice. Notably, this was accompanied by increased hepatic abundances of Fusobacterium , Pseudomonas , and Campylobacter , as well as decreased abundances of Bifidobacterium and Muribaculaceae . However, in antibiotic‐pretreated Mdr2 −/− mice, Kp‐OMVs aggravated hepatic inflammation and fibrosis but failed to induce intestinal barrier disruption. In vitro , treatment with Kp‐OMVs further enhanced inflammation, induced senescence, and suppressed proliferation in IL‐17A‐stimulated cholangiocyte organoids, whereas Escherichia coli ‐derived OMVs (Ec‐OMVs) did not elicit these effects. Mechanistically, Kp‐OMVs upregulated the NF‐kappa B, TNF, cytokine‐cytokine receptor, and IL‐17 signalling pathways in organoids. In conclusion, Kp‐OMVs aggravate PSC via gut‐liver axis disruption and activation of inflammatory signalling pathways, offering a potential therapeutic target for future intervention in PSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingKlebsiella pneumoniaeInterleukin-17OrganoidsBacterial Outer MembraneATP Binding Cassette Transporter, Subfamily BAnimalsMiceMice, KnockoutATP-Binding Cassette Sub-Family B Member 4LiverDisease Models, AnimalMice, Inbred C57BLMale

Stichwörter der Autor:innen

Klebsiella pneumoniaecholangiocyte organoidsgut‐liver axisouter membrane vesiclesprimary sclerosing cholangitis

Substanzen

Interleukin-17ATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Developme…
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
  • Yuhang Institute for Collaborative Innovation and Translational Research in Life Sciences and Technology, Hangzhou, China.

ORCID-Profile: Lanjuan Li

Förderung

  • Key R&D Program of Shandong Province
  • National Key R&D Program of China
  • Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Research Project of Jinan Microecological Biomedicine Shangdong Laboratory
  • Shandong Provincial Laboratory Project
  • Central Guidance Fund for Local Science and Technology Development
  • National Natural Science Foundation of China

Zitieren

APA

Yin, P., Wang, K., Wu, Y., Wang, F., Zhao, Y., Ni, J., Song, T., Chen, Y., & Li, L. (2026). Outer Membrane Vesicles Derived From Klebsiella pneumoniae Aggravate Primary Sclerosing Cholangitis in Mdr2 −/− Mice and IL‐17A‐Stimulated Cholangiocyte Organoids. Journal of Extracellular Vesicles, 15(11). https://doi.org/10.1002/jev2.70402

Vancouver

Yin P, Wang K, Wu Y, Wang F, Zhao Y, Ni J, et al. Outer Membrane Vesicles Derived From Klebsiella pneumoniae Aggravate Primary Sclerosing Cholangitis in Mdr2 −/− Mice and IL‐17A‐Stimulated Cholangiocyte Organoids. Journal of Extracellular Vesicles. 2026;15(11). doi:10.1002/jev2.70402

BibTeX
@article{Yin2026,
  author = {Yin, Pengyu and Wang, Kaicen and Wu, Yechen and Wang, Fengjiao and Zhao, Yuxi and Ni, Jiali and Song, Tinglei and Chen, Yanfei and Li, Lanjuan},
  title = {Outer Membrane Vesicles Derived From Klebsiella pneumoniae Aggravate Primary Sclerosing Cholangitis in Mdr2 −/− Mice and IL‐17A‐Stimulated Cholangiocyte Organoids},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/jev2.70402}
}
Kostenlos starten →